Acquisition Biotech China Chinese Covid-19 Electronics Guangdong Healthcare Manufacturer Manufacturing Medicine Pandemic Procurement Shanghai Shenzhen Supply Chain Technology
Mergers and acquisitions (M&As) in the Chinese medical device sector have greatly increased since 2018. According to GlobalData's Medical Devices Deal Database, the number of key M&A activities in major markets almost quadrupled from 2018 to 2021. GlobalData expects a similar trend will continue this year. In-vitro diagnostics (IVD) remains the most active market for investors in China, especially in areas related to Covid-19 tests. The medical device industry has been facing fierce competition due to China's volume-based procurement policy in recent years. The players in the medical devices market have been under pressure for organic growth. In addition, device…
News Timeline:
Track the development of this news story across the Internet.